More Business Wire

View Older Stories View Newer Stories

Feb 20, 2024 08:08AM Rancher Government Releases Hauler to Streamline and Accelerate the Transfer of Assets Across Airgap Environments Securely.
Feb 20, 2024 08:08AM Aya Healthcare Receives Best of Client Satisfaction Award from ClearlyRated
Feb 20, 2024 08:08AM Charles River Collaborates with Pluristyx, Expanding its Portfolio of Human Pluripotent Stem Cells
Feb 20, 2024 08:05AM SAIC to Host Investor Day in New York City on April 11, 2024
Feb 20, 2024 08:05AM Ameresco Begins Operations of 5.2 MWe Renewable Natural Gas Plant at Republic Services’ Brickyard Landfill
Feb 20, 2024 08:05AM Farmers & Merchants Bank of Long Beach Declares First-Quarter Cash Dividend Payment of $28 Per Share
Feb 20, 2024 08:05AM PetroSure Partners with AmTrust to Deliver Workers’ Compensation Coverage to the Upstream Onshore Oil and Gas Industry
Feb 20, 2024 08:02AM Arcadia Biosciences (RKDA) Expands GoodWheat™ Mac & Cheese with Nationwide Availability
Feb 20, 2024 08:02AM Applebee’s® Brings Back $5 Tipsy Leprechaun and NEW Pot O’ Gold Daq-A-Rita Cocktails for St. Patrick’s Day
Feb 20, 2024 08:02AM USAA Bank Raises the Bar Among Financial Services, While Credit Unions Bounce Back After 5-Year Slide, ACSI Data Show
Feb 20, 2024 08:01AM Veradigm Reveals New Insights on the Prevalence of Cardiovascular Conditions in the U.S.
Feb 20, 2024 08:00AM UFP Industries Announces Fourth Quarter and Fiscal 2023 Results
Feb 20, 2024 08:00AM Metomic’s New Human Firewall Features Enable Security And Compliance Teams To Scale Data Security Workflows, Providing Real-time Risk Remediation
Feb 20, 2024 08:00AM BioTalent Canada and CASTL partner to support talent development in Canada’s biomanufacturing sector
Feb 20, 2024 08:00AM Koneksa Enrolls First Patient in LEARNS Observational Study to Remotely Measure Disease Progression Using Digital Biomarkers in Neurodegenerative Disorders
Feb 20, 2024 08:00AM Resilience Expands Clinical and Commercial Drug Product Manufacturing Capabilities and Capacities
Feb 20, 2024 08:00AM GoTo Group, Inc. Announces Early Tender Results and Expected Settlement of Exchange Offer for 5.50% Senior Secured Notes Due 2027
Feb 20, 2024 08:00AM Western Asset Term Funds Announce Stockholder Proposals
Feb 20, 2024 08:00AM Janux Therapeutics to Host Virtual Event Discussing Updated Clinical Data for PSMA-TRACTr JANX007 and EGFR-TRACTr JANX008
Feb 20, 2024 08:00AM Enevate Licensee JR Energy Solution Starts Operation of Korea’s First Electrode Foundry
Feb 20, 2024 08:00AM Skillsoft Advances Technology Skills Training for the AI Era With New Codecademy Learning Experiences
Feb 20, 2024 08:00AM AffyImmune Therapeutics to Participate in a Fireside Chat at the Evercore ISI 2024 Emerging Biotech Conference
Feb 20, 2024 08:00AM Digimarc Collaborates with GS1 to Advance GS1 Digital Link
Feb 20, 2024 08:00AM Pagaya Names Evangelos Perros as Chief Financial Officer
Feb 20, 2024 08:00AM Franklin Templeton Fund Adviser, LLC Announces Distributions for the Months of March, April and May 2024
Feb 20, 2024 08:00AM XPANCEO to Develop the First Laboratory Optic Testing System to Accelerate Smart Contact Lens Production Worldwide
Feb 20, 2024 08:00AM Natera Announces Fourth Quarter and Fiscal 2023 Earnings Conference Call
Feb 20, 2024 08:00AM Nordson Corporation Elects Annette Clayton to its Board of Directors
Feb 20, 2024 08:00AM Intercontinental Exchange, Inc. Commences Consent Solicitation with Respect to Black Knight InfoServ, LLC’s Outstanding 3.625% Senior Notes Due 2028
Feb 20, 2024 08:00AM Montrose Environmental Group Upsizes Credit Facility to $400 Million
Feb 20, 2024 08:00AM JonesTrading Rapidly Deploys FlexOMS to Power its Sell-Side Trading Desks
Feb 20, 2024 08:00AM Avanci Welcomes the Volkswagen Group to its 5G Vehicle Licensing Program
Feb 20, 2024 08:00AM Divcon Controls Announces Investment from Goldman Sachs Alternatives
Feb 20, 2024 08:00AM Fifth Third Opens Tampa, FL-based Fifth Third Wealth Advisors Office
Feb 20, 2024 08:00AM Franklin Templeton Fund Adviser, LLC Announces Distributions for Certain Closed End Funds Pursuant to their Managed Distribution Policy for the Months of March, April and May 2024
Feb 20, 2024 08:00AM Applebee’s® 2 for $25 Menu Debuts NEW Sizzlin’ Skillets
Feb 20, 2024 08:00AM ICE Reports Record Open Interest of Over 90 Million Contracts Across Total Futures and Options Markets
Feb 20, 2024 08:00AM Franklin Templeton Fund Adviser, LLC Announces Distributions for Certain Closed-End Funds Pursuant to their Managed Distribution Policy for the Months of March, April and May 2024
Feb 20, 2024 08:00AM Dynatrace to Present at Upcoming Investor Conference
Feb 20, 2024 08:00AM Acacia Research Expands Oil and Gas Investments Through Benchmark Energy’s Transformative Acquisition in the Western Anadarko Basin
Feb 20, 2024 08:00AM Predibase Announces LoRA Land – Dozens of Efficiently Fine-tuned LLMs That Outperform GPT-4 All Served From a Single GPU
Feb 20, 2024 08:00AM Access to Prescribed PCSK9 Inhibitors Remains a Significant Barrier Leaving Patients at Risk for Heart Attacks and Strokes
Feb 20, 2024 08:00AM Nova Credit Partners with SafeRent Solutions, Further Expanding Income Navigator Solution in the Property Management Sector
Feb 20, 2024 08:00AM NeueHealth to Host Fourth Quarter 2023 Earnings Conference Call on March 6, 2024
Feb 20, 2024 08:00AM The 29th Annual 2024 New York Sohn Investment Conference to Convene Top Hedge Fund Leaders and Global Investors on April 3 in New York City
Feb 20, 2024 08:00AM Spirent Report: 5G Standalone and Private Networks Ready to be Unleashed
Feb 20, 2024 08:00AM Reprieve Cardiovascular Emerges from Stealth Mode after $42 Million Series A Financing to Bring Intelligent Fluid Management to Heart Failure Patients
Feb 20, 2024 08:00AM AtmosZero Closes $21 Million in Series A, Moves Full Steam Ahead Toward Electrifying the Boiler Room
Feb 20, 2024 08:00AM Astria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma & Immunology Annual Meeting
Feb 20, 2024 08:00AM NextPoint Therapeutics Announces First Patient Dosed in Phase 1a/b Clinical Trial of NPX887, a Novel Therapeutic Targeting HHLA2 to Reactivate Exhausted T and NK Cells in HHLA2+ Solid Tumors
View Newer Stories View Older Stories